Farah Champsi, Director at Kite Pharma, Inc. (KITE), sold 25,900 shares at $88.11 ($2.3M) on 2017-06-16, disclosed to the SEC on 2017-06-16.
Open-market sale of $2.3M KITE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.40 | 15,000 | $1.4M | 58.5% |
| 2 | $88.11 | 5,450 | $480K | 20.7% |
| 3 | $88.11 | 5,450 | $480K | 20.7% |
| Total | $89.44 avg | 25,900 | $2.3M | 100% |
| Filing → |
| KITE | SELL | 2017-04-17 | $19.0M | — | Filing → |
| KITE | SELL | 2015-07-02 | $41.4M | — | Filing → |
| CMRX | SELL | 2013-10-23 | $6.9M | — | Filing → |